28 Result(s)

Article

A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [¹⁷⁷Lu]Lu-LNC1003 in patients with metastatic castration-resistant prostate cancer

This translational study aimed to determine the maximum tolerated dose (MTD), safety, dosimetry, and therapeutic efficacy of ¹⁷⁷Lu-PSMA-EB-01 (denoted as [¹⁷⁷Lu]Lu-LNC1003) in patients with metastatic castration-...

Jie Zang, Guochang Wang, Tianzhi Zhao… in European Journal of Nuclear Medicine and M… (2024)

Article

SSTR antagonist [⁶⁸Ga]Ga-DOTA-LM3 differentiates intrapancreatic accessory spleen from neuroendocrine tumor in a patient presenting indeterminate MRI and SSTR agonist [⁶⁸Ga]Ga-DOTATATE

Weizhi Xu, Jiayu Cai, Tinghua Meng… in European Journal of Nuclear Medicine and M… (2024)

Article

FAP expression in alpha cells of Langherhans insulae—implications for FAPI radiopharmaceuticals’ use

Radiopharmaceuticals targeting fibroblast activation protein (FAP) alpha are increasingly studied for diagnostic and therapeutic applications. We discovered FAP expression at immunohistochemistry (IHC) in the ...

Margarita Kirienko, Giovanni Centonze… in European Journal of Nuclear Medicine and M… (2023)

Article

Extranodal Rosai-Dorfman disease involving pulmonary artery detected by ⁶⁸Ga-FAPI PET/CT and fused ⁶⁸Ga-FAPI PET/MRI

Liang Zhao, Yizhen Pang, Long Sun, Qin Lin… in European Journal of Nuclear Medicine and M… (2023)

Article

Identification of isolated hepatic sarcoidosis with [¹⁸F]FDG and [⁶⁸ Ga]Ga-FAPI PET/CT

Yizhen Pang, Peipei Wang, Weizhi Xu… in European Journal of Nuclear Medicine and M… (2023)

Article

[⁶⁸ Ga]Ga-DOTATATE PET/CT versus [⁶⁸ Ga]Ga-Exendin-4 PET/CT in the evaluation of metastatic insulinoma

Wei Guo, Yuhang Chen, **aojiang He, Hao Fu… in European Journal of Nuclear Medicine and M… (2023)

Article

Comparison of [⁶⁸Ga]Ga-FAPI and [¹⁸F]FDG uptake in patients with gastric signet-ring-cell carcinoma: a multicenter retrospective study

In this study, we investigated the role of [⁶⁸Ga]Ga-FAPI PET imaging in the detection of primary and metastatic gastric signet-ring-cell carcinoma (GSRCC) and compared with [¹⁸F]FDG PET.

Haojun Chen, Yizhen Pang, Junpeng Li, Fei Kang, Weizhi Xu… in European Radiology (2023)

Article

Prognostic value of fibroblast activation protein expressing tumor volume calculated from [⁶⁸ Ga]Ga-FAPI PET/CT in patients with esophageal squamous cell carcinoma

This study aimed to investigate the prognostic value of semiquantitative parameters derived from [⁶⁸ Ga]Ga-fibroblast activation protein inhibitor (FAPI) PET/CT for patients with esophageal squamous cell carcinom...

Liang Zhao, Yizhen Pang, Shanyu Chen… in European Journal of Nuclear Medicine and M… (2023)

Article

⁶⁸Ga-FAPI PET/CT detected non-FDG-avid bone metastases in breast cancer

Qihang Shang, Bing Hao, Weizhi Xu… in European Journal of Nuclear Medicine and M… (2022)

Article

[⁶⁸Ga]Ga-FAPI PET/CT imaging of brown tumors in a patient with primary hyperparathyroidism

Yizhen Pang, Qihang Shang, Tinghua Meng… in European Journal of Nuclear Medicine and M… (2022)

Article

FAP-targeted radionuclide therapy with [¹⁷⁷Lu]Lu-FAPI-46 in metastatic nasopharyngeal carcinoma

Kaili Fu, Yizhen Pang, Liang Zhao, Limei Lin… in European Journal of Nuclear Medicine and M… (2022)

Article

Positron emission tomography and computed tomography with [⁶⁸Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer

This study aimed to investigate the diagnostic performance of [⁶⁸Ga]Ga-FAPI PET/CT for primary and metastatic pancreatic carcinoma lesions and compare the results with those of [¹⁸F]-fluorodeoxyglucose ([¹⁸F]FDG)...

Yizhen Pang, Long Zhao, Qihang Shang… in European Journal of Nuclear Medicine and M… (2022)

Article

Somatostatin receptor imaging with [⁶⁸Ga]Ga-DOTATATE positron emission tomography/computed tomography (PET/CT) in patients with nasopharyngeal carcinoma

To explore the feasibility of [⁶⁸Ga]Ga-DOTATATE positron emission tomography/computed tomography (PET/CT) in patients with non-keratinizing nasopharyngeal carcinoma (NPC) and to evaluate whether [⁶⁸Ga]Ga-DOTATATE...

Liang Zhao, Yizhen Pang, Yuhuan Wang… in European Journal of Nuclear Medicine and M… (2022)

Article

Increased [⁶⁸ Ga]Ga-FAPI uptake in focal nodular hyperplasia in a patient with sigmoid colon cancer

Qihang Shang, Li Fu, Yizhen Pang… in European Journal of Nuclear Medicine and M… (2021)

Article

Clinical utility of [⁶⁸Ga]Ga-labeled fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography for primary staging and recurrence detection in nasopharyngeal carcinoma

This study aimed to explore the clinical utility of [⁶⁸Ga]Ga-labeled fibroblast activation protein inhibitor ([⁶⁸Ga]Ga-FAPI) positron emission tomography/computed tomography (PET/CT) relative to [¹⁸F]-fluorodeoxy...

Liang Zhao, Yizhen Pang, Hua Zheng… in European Journal of Nuclear Medicine and M… (2021)

Article

Role of [⁶⁸Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of peritoneal carcinomatosis and comparison with [¹⁸F]-FDG PET/CT

The aim of this study was to explore the role of [⁶⁸Ga]Ga-DOTA-FAPI-04 positron emission tomography/computed tomography (PET/CT), compared with ¹⁸F-fluorodeoxyglucose [¹⁸F]-FDG PET/CT, for evaluating peritoneal c...

Liang Zhao, Yizhen Pang, Zuoming Luo… in European Journal of Nuclear Medicine and M… (2021)

Article

Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [⁶⁸Ga]Ga-FAPI-04 PET/CT versus MRI and [¹⁸F]-FDG PET/CT

This study aimed to evaluate the potential utility of [⁶⁸Ga]Ga-FAPI-04 PET/CT for diagnosing primary and metastatic lesions in patients with liver cancer, as well as to compare it with contrast-enhanced CT (CE-CT...

Wei Guo, Yizhen Pang, Lanlin Yao, Liang Zhao… in European Journal of Nuclear Medicine and M… (2021)

Article

[¹⁸F]FDG and ^[68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of tuberculous lesions

Bing Hao, **urong Wu, Yizhen Pang, Long Sun… in European Journal of Nuclear Medicine and M… (2021)